Marcum Conference Archives - Page 2 of 12

FridayJun 16, 2017 10:30 am

InspireMD, Inc. (NYSE: NSPR) Starts Presentation at the 2017 Marcum Microcap Conference

InspireMD (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which it both manufactures and commercializes. Today, InspireMD is a global company headquartered in Boston, MA. InspireMD seeks to utilize its proprietary MicroNetTM technology to make its products the industry standard for embolic protection by providing a superior solution to the key clinical issues of vascular procedures. For more information, visit the company's website at inspiremd.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service…

FridayJun 16, 2017 10:00 am

Orgenesis, Inc. (ORGS) Starts Presentation at the 2017 Marcum Microcap Conference

Orgenesis (OTC: ORGS) is a biopharmaceutical company with unique expertise and experience in cell therapy development and manufacturing. The company's MaSTherCell subsidiary is able to deliver optimized process industrialization capacities to cell therapy companies. MaSTherCell's customers include many of the world's leading pharmaceutical and biotech companies. Orgenesis is a pioneer in the process of trans-differentiation (cell reprograming), whereby an adult cell is converted into another type of cell. Orgenesis has successfully reprogramed human liver cells into glucose-responsive, fully functional, insulin producing cells. For more information, visit the company's website at www.orgenesis.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

FridayJun 16, 2017 10:00 am

VolitionRX Ltd. (NYSE: VNRX) Starts Presentation at the 2017 Marcum Microcap Conference

VolitionRX (NYSE: VNRX) is a multi-national life sciences company developing simple, easy to use blood-based cancer tests to accurately diagnose a range of cancers. The tests are based on the science of Nucleosomics®, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid -- an indication that disease is present. The company’s products aim to help to diagnose a range of cancers quickly, simply, accurately and cost effectively since early diagnosis often has the potential to prolong the life of patients. For more information, visit the company's website at www.volitionrx.com About NetworkNewsWire NetworkNewsWire (NNW)…

FridayJun 16, 2017 10:00 am

MagneGas Corporation (NASDAQ: MNGA) Starts Presentation at the 2017 Marcum Microcap Conference

MagneGas (NASDAQ: MNGA) owns a patented process that converts various renewables and liquid wastes into MagneGas fuels. These fuels can be used as an alternative to natural gas or for metal cutting. The company's testing has shown that its metal cutting fuel "MagneGas2®" is faster, cleaner and more productive than other alternatives on the market. It is also cost effective and safe to use with little changeover costs. The company currently sells MagneGas2® into the metal working market as a replacement to acetylene. For more information, visit the company's website at www.magnegas.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that…

FridayJun 16, 2017 10:00 am

NeuroMetrix, Inc. (NASDAQ: NURO) Starts Presentation at the 2017 Marcum Microcap Conference

NeuroMetrix (NASDAQ: NURO) is a commercial stage, innovation driven healthcare company combining bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The company's lead product is Quell, an over-the-counter wearable therapeutic device for chronic pain. Quell is integrated into a digital health platform that helps patients optimize their therapy and decrease the impact of chronic pain on their quality of life. The company also markets DPNCheck®, a rapid point-of-care test for diabetic neuropathy. For more information, visit the company's website at www.neurometrix.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to…

FridayJun 16, 2017 10:00 am

RespireRx Pharmaceuticals, Inc. (RSPI) Starts Presentation at the 2017 Marcum Microcap Conference

RespireRx Pharmaceuticals (OTC: RSPI) is focused on developing drug candidates to treat very large respiration related markets that are unserved or poorly served. RespireRx is also developing drugs for niche respiratory markets where premium pricing is probable. The company’s current efforts are involved with sleep apnea/hypopnea, respiratory depression and respiratory distress. The company owns patents and patent applications, and holds exclusive licenses, for certain families of chemical compounds that claim the chemical structures and their use in the treatment of these and other disorders. For more information, visit the company's website at www.respirerx.com About NetworkNewsWire NetworkNewsWire (NNW) is an information…

FridayJun 16, 2017 9:30 am

Mateon Therapeutics, Inc. (MATN) Starts Presentation at the 2017 Marcum Microcap Conference

Mateon Therapeutics (OTC: MATN) is a biopharmaceutical company focused on vascular targeted therapy (VTT) in oncology. VTT includes vascular disrupting agents (VDAs) such as the investigational drugs that Mateon is developing, and anti-angiogenic agents(AAs), which are FDA-approved and widely used in cancer treatment. These two approaches have distinct yet complementary mechanisms of action. The company believes it can significantly improve cancer therapy by employing these two complementary approaches simultaneously. When utilized this way, VDAs obstruct existing blood vessels in the tumor leading to central tumor cell death while AAs prevent formation of new tumor blood vessels. For more information, visit…

FridayJun 16, 2017 9:30 am

AEterna Zentaris, Inc. (NASDAQ: AEZS) Starts Presentation at the 2017 Marcum Microcap Conference

AEterna Zentaris (NASDAQ: AEZS) is a specialty biopharmaceutical company engaged in developing and commercializing novel pharmaceutical therapies. The company recently completed phase 3 studies of two internally developed compounds and intends to license out certain commercial rights of internally developed products to licensees in non-U.S. territories where such out-licensing would enable the company to ensure development, registration and launch of its product candidates. For more information, visit the company's website at www.aezsinc.com About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users (1) access to our news aggregation and syndication servers, (2) enhanced press release services, and (3)…

ThursdayJun 15, 2017 4:30 pm

Genoil Inc. (GNOLF) Starts Presentation at the 2017 Marcum Microcap Conference

Genoil (OTC: GNOLF) is a clean technology engineering company for the petroleum industries. Genoil has developed its proprietary technology, the Hydroconversion Upgrader (GHU), which converts heavy crude oils and refinery bottoms into clean burning fuels for transportation industries including shipping. The GHU can be placed in remote locations, including receiving terminals, pipelines and ports. The company operates one of the largest and most advanced pilot & design test facilities in the world, from its 147-acre site in Alberta, Canada. For more information, visit the company's website at www.genoil.ca About NetworkNewsWire NetworkNewsWire (NNW) is an information service that provides to users…

ThursdayJun 15, 2017 4:30 pm

Exactus, Inc. (EXDI) Starts Presentation at the 2017 Marcum Microcap Conference

Exactus (OTC: EXDI) is a life science company developing and commercializing point-of-care (POC) diagnostics for measuring proteolytic enzymes in the blood. The company’s lead product, the FibriLyzer™, is being developed to assess the fibrinolytic status to speed treatment decisions for patients who are at risk of hemorrhage. The company’s second product candidate, the MatriLyzer™, may be used to detect the recurrence of cancer and can be used as an at-home monitoring device or during routine office visits. The MatriLyzer™ can communicate directly with the attending oncologist via a smart phone application to ensure that the tests are being used properly and to…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Category: Marcum Conference

InspireMD, Inc. (NYSE: NSPR) Starts Presentation at the 2017 Marcum Microcap Conference

Orgenesis, Inc. (ORGS) Starts Presentation at the 2017 Marcum Microcap Conference

VolitionRX Ltd. (NYSE: VNRX) Starts Presentation at the 2017 Marcum Microcap Conference

MagneGas Corporation (NASDAQ: MNGA) Starts Presentation at the 2017 Marcum Microcap Conference

NeuroMetrix, Inc. (NASDAQ: NURO) Starts Presentation at the 2017 Marcum Microcap Conference

RespireRx Pharmaceuticals, Inc. (RSPI) Starts Presentation at the 2017 Marcum Microcap Conference

Mateon Therapeutics, Inc. (MATN) Starts Presentation at the 2017 Marcum Microcap Conference

AEterna Zentaris, Inc. (NASDAQ: AEZS) Starts Presentation at the 2017 Marcum Microcap Conference

Genoil Inc. (GNOLF) Starts Presentation at the 2017 Marcum Microcap Conference

Exactus, Inc. (EXDI) Starts Presentation at the 2017 Marcum Microcap Conference

NetworkNewsWire Currently Accepts

NetworkNewsWire

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsWire Currently Accepts

Company Search

Site Search